Literature DB >> 20009407

The middle meningial artery during a migraine attack: 3T magnetic resonance angiography study.

Eiichiro Nagata1, Hisamoto Moriguchi, Shunya Takizawa, Tomohiko Horie, Noriharu Yanagimachi, Shigeharu Takagi.   

Abstract

We performed 3T magnetic resonance angiography (MRA) during a spontaneous migraine attack. The patient was a 42-year-old woman migraineur diagnosed by the IHS criteria. The change of the middle meningial artery (MMA) was measured on the axial brain images using MATLAB for three phases (attack-free period, during an attack, a period after medication). There were no dramatic changes of vasodilation in the MMA during the attack (2.0 mm), attack-free period (diameter 1.9 mm), or period after medication (1.7 mm), resembling extrapolations of observations in experimental animal models. This finding suggests that the dramatic vasomotion might not be associated with migraine pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009407     DOI: 10.2169/internalmedicine.48.2565

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Clinical importance of the middle meningeal artery: A review of the literature.

Authors:  Jinlu Yu; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

Review 2.  Mechanisms of migraine as a chronic evolutive condition.

Authors:  Anna P Andreou; Lars Edvinsson
Journal:  J Headache Pain       Date:  2019-12-23       Impact factor: 7.277

3.  Course of Preexisting Migraine Following Spontaneous Subarachnoid Hemorrhage.

Authors:  José Manuel Valdueza; Jens Peter Dreier; Johannes Woitzik; Christian Dohmen; Oliver Sakowitz; Johannes Platz; Stefanie Leistner-Glaess; Victoria Dorothea Witt
Journal:  Front Neurol       Date:  2022-07-11       Impact factor: 4.086

4.  Cerebral Hemodynamic Changes During Migraine Attacks and After Triptan Treatments.

Authors:  Bilgin Öztürk; Ömer Karadaş
Journal:  Noro Psikiyatr Ars       Date:  2019-02-12       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.